Business Context and Reporting Period
Company: vTv Therapeutics Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 17, 2022
Reporting Period: Event date February 17, 2022; Report signed February 18, 2022.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a regulatory compliance event regarding stock listing status.
Material Changes
The Company received a notification from The NASDAQ Stock Market LLC on February 17, 2022, stating it is not in compliance with NASDAQ Rule 5550(a)(2). This non-compliance is due to the closing bid price of the Company's Class A common stock remaining below $1.00 per share for 30 consecutive business days.
Outlook, Risks, and Management Commentary
- Compliance Period: The Company has 180 calendar days, until August 16, 2022, to regain compliance.
- Remediation Path: Compliance can be achieved if the closing bid price is at or above $1.00 per share for a minimum of 10 consecutive business days during the 180-day period.
- Current Status: The notification has no immediate effect on the listing of the Class A Common Stock on The NASDAQ Capital Market.
- Management Action: The Company intends to actively monitor the closing bid price and is evaluating available options to regain compliance.
- Risks: There is no assurance that the Company will regain compliance. Failure to do so may result in the removal of the Class A Common Stock from The NASDAQ Capital Market, subject to an appeals process.
Investor Verification Checklist
- Verify the current closing bid price of vTv Therapeutics Inc. Class A common stock (VTVT) to assess proximity to the $1.00 threshold.
- Monitor the stock price for 10 consecutive business days to determine if the Company has met the initial compliance criteria.
- Review subsequent filings for any announcements regarding reverse stock splits or other corporate actions intended to address the minimum bid price requirement.
- Confirm the Company's cash position and liquidity in recent 10-Q or 10-K filings, as this filing does not contain financial data.